|
- 340B Drug Pricing Program | HRSA
The 340B Program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services Manufacturers participating in Medicaid agree to provide outpatient drugs to covered entities at significantly reduced prices
- 340B Eligibility | HRSA
Discover eligibility and registration details for HRSA's 340B Drug Pricing Program to help entities access discounted medications
- 340B Educational Resources | HRSA
Our website provides resources to help 340B Program stakeholders with navigating the 340B Program, including registration and implementation, requirements compliance, program integrity, and more:
- Program Requirements | HRSA
Covered entities must meet these requirements to purchase drugs at 340B prices: Keep 340B Office of Pharmacy Affairs Information System (OPAIS) records accurate and up to date
- 340B Office of Pharmacy Affairs Information System | HRSA
We have developed a new, integrated information system that focuses on three key priorities: security, user accessibility, and data accuracy The 340B registration and pricing databases are known as the 340B Office of Pharmacy Affairs Information System (340B OPAIS)
- Ceiling Price Lookup
Under section 340B (a) of the Public Health Service Act (PHSA), the 340B ceiling price is calculated by subtracting the unit rebate amount (URA) from the average manufacturer price (AMP) for the smallest unit of measure of each covered outpatient drug (as identified by the product's 11-digit National Drug Code (NDC)
- Office of Pharmacy Affairs 340B OPAIS
Have questions? Contact the 340B Prime Vendor www 340bpvp com 1-888-340-2787 8AM-5PM CT Mon-Fri
- 340B Patient Definition Compliance Resources | HRSA
HRSA’s 340B Program audits review covered entity compliance with several statutory provisions, including eligibility status, duplicate discounts, and diversion in accordance with sections 340B (a) (4), (5) (A) and (B) of the PHSA
|
|
|